Crossmark

Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?

Published Online: 2023-02-05

Published Print: 2023-03-11

Authors

Bakırcı, Şükrü https://orcid.org/0000-0002-6007-965X
Kurdoğlu, Mertihan https://orcid.org/0000-0002-5344-9739
Khaki, Arash https://orcid.org/0000-0002-4678-4002
More Information

Journal Owner: Aras Part Medical International Press

Journal Publisher: Aras Part Medical International Press

Publication History

Received: 2023-01-03

Accepted: 2023-01-25

Published: 2023-02-05

Document is current